Harvard Bioscience (HBIO) Amortization of Goodwill (2025)

Harvard Bioscience's (HBIO) quarterly Amortization of Goodwill came in at $48.0 million in Q1 2025.

Harvard Bioscience (HBIO) Amortization of Goodwill (2025) Analysis & Trends

Harvard Bioscience (HBIO) has 1 years of Amortization of Goodwill data on file, last reported at $48.0 million in Q1 2025.

On a quarterly basis, Amortization of Goodwill changed N/A year-over-year to $48.0 million in Q1 2025; TTM through Dec 2025 was $48.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $48.0 million, changed N/A from the prior year.
Amortization of Goodwill for Q1 2025 stood at $48.0 million.
Over the last five years, Amortization of Goodwill for HBIO reached as high as $48.0 million in Q1 2025 and fell as low as $48.0 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Harvard Bioscience	28.05 Mn	20.96 Mn	12.24 Mn

Download Data

Date	Value
Mar 31, 2025	47.95 Mn
Mar 31, 2025	47.95 Mn